SCHEMBL7790507

SCHEMBL7790507

OC1CCC(Nc2ccccc2Cl)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ BTK Q06187 1/20 0.43
▸ MAPK3 P27361 1/20 0.43
▸ ADORA1 P30542 2/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ GRM2 Q14416 3/20 0.40
▸ PDE2A O00408 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19403829 0.82 KDM4E (0.58) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL19139395 0.81 PKM (0.47) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5046395 0.81 KDM4E (0.61) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL7794045 0.79 RAB9A (0.48) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL28642573 0.78 KDM4E (0.68) KMT2AALDH1A1ADORA1ADORA2AKDM4E
SCHEMBL21310837 0.78 KDM4E (0.68) KMT2AALDH1A1ADORA1ADORA2AKDM4E
SCHEMBL28642570 0.78 KDM4E (0.68) KMT2AALDH1A1ADORA1ADORA2AKDM4E
SCHEMBL83169 0.78 CYP1A2 (0.48) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2092342 0.78 KMT2A (0.45) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL68901 0.76 CYP1A2 (0.47) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 — — EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 — — WO disclosed
Send feedback